JNJ Insider Trading Activity and SEC Form 4 Filings
Trump's trades in JNJ
From his financial disclosures
$463K+
12 purchases
$633K+
7 sales
Purchase
Jul 31, 2026
Reported 53d later
$100K - $250K
Sale
Jun 23, 2026
Reported 60d later
$1K - $15K
Sale
Jun 16, 2026
Reported 67d later
$15K - $50K
Purchase
Jun 15, 2026
Reported 68d later
$1K - $15K
Purchase
Jun 12, 2026
Reported 71d later
$100K - $250K
Purchase
May 18, 2026
Reported 44d later
$15K - $50K
Many orders in these accounts are placed by the account manager. See all 19 trades
JNJ insider trading summary
Over the past 12 months, insiders at Johnson & Johnson (JNJ) reported 28 sales worth $150.7M by 10 insiders and 1 open-market purchase worth $258K by 1 insider on SEC Form 4. Net insider selling was $150.4M.
Latest JNJ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Timothy Schmid | EVP, WW Chair, MedTech | Sell | $3.0M (11,070 @ $274.74) |
| Sep 2, 2026 | Timothy Schmid | EVP, WW Chair, MedTech | Sell | $6.2M (22,527 @ $274.74) |
| Aug 17, 2026 | Jennifer L Taubert | EVP, WWC. Innovative Medicine | Sell | $4.0M (15,000 @ $263.36) |
| Aug 13, 2026 | Joaquin Duato | CEO and Chairman of the Board | Sell | $26.7M (102,315 @ $261.00) |
| Aug 13, 2026 | Joaquin Duato | CEO and Chairman of the Board | Sell | $5.5M (20,976 @ $262.00) |
| Aug 6, 2026 | Elizabeth Forminard | EVP, Chief Legal Officer | Sell | $2.4M (9,344 @ $257.75) |
| Aug 6, 2026 | Elizabeth Forminard | EVP, Chief Legal Officer | Sell | $1.7M (6,574 @ $255.93) |
| Aug 5, 2026 | Joaquin Duato | CEO and Chairman of the Board | Sell | $1.7M (6,523 @ $258.74) |
| Aug 5, 2026 | Joaquin Duato | CEO and Chairman of the Board | Sell | $10.8M (41,957 @ $258.06) |
| Jul 20, 2026 | Vanessa Broadhurst | EVP, Global Corp Affairs | Sell | $5.8M (23,054 @ $251.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.